InsiderClue
← All stocks

ANAPTYSBIO, INC

ANAB Net buying
CIK 0001370053 #2173 in the set updated 19 Sep 2026
Bought (120 mo)
$116.61M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$81.35M
$463.54K on a plan · $27.71M straight out of an exercise
Sold at will
$53.18M
66 of 140 sales
Net
+$35.25M
+$63.43M against sales at will

By person

22 insiders · 179 transactions
40.3×

Daniel Faga holds 40.3 times base salary in stock. $28.47M of shares against $706.01K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Faga last reported holding, valued at $57.40, the price Common Stock was last bought or sold at on the open market here, on 30 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
EcoR1 Capital, LLC entity
Director
$97.56M (14)
$14.45M (1)
+$83.10M
15,400,518
52.92%
$883.97M
+35.9%
Novo Holdings A/S entity
10% owner
$750.00K (1)
$23.32M (9)
−$22.57M
1,936,604
6.65%
$111.16M
—
Suria Hamza
President, CEO
—
$15.75M (25) scheduled
−$15.75M
68,600
0.2357%
$3.94M
—
Faga Daniel
President, CEO
—
$6.34M (16)
−$6.34M
495,965
1.70%
$28.47M
+12,247%
Frazier Healthcare V, LP entity
10% owner
$6.00M (2)
—
+$6.00M
1,062,321
3.65%
$60.98M
—
Frazier Healthcare VII, L.P.
10% owner
$6.00M (2)
—
+$6.00M
1,284,903
4.42%
$73.75M
—
Topper James N
Director
$6.00M (2)
—
+$6.00M
980,512
3.37%
$56.28M
+736.4%
LOUMEAU ERIC J
CHIEF LEGAL OFFICER
—
$4.40M (26) scheduled
−$4.40M
12,835
0.0441%
$736.71K
+157.0%
Londei Marco
Chief Medical Officer
—
$4.07M (9) scheduled
−$4.07M
68,579
0.2357%
$3.94M
—
Piscitelli Dominic
Chief Financial Officer
—
$2.67M (6) scheduled
−$2.67M
0
0.0000%
$0.00
—
Lydon Nicholas
Director
$249.99K (1)
$2.87M (7)
−$2.62M
271,106
0.9316%
$15.56M
+302.6%
MULROY DENNIS
CHIEF FINANCIAL OFFICER
—
$2.31M (13) scheduled
−$2.31M
21,852
0.0751%
$1.25M
+474.3%
RENTON HOLLINGS
Director
—
$1.37M (9) scheduled
−$1.37M
10,995
0.0378%
$631.10K
—
Schmid John P.
Director
—
$1.16M (3)
−$1.16M
37,652
0.1294%
$2.16M
—
Avalon Ventures VII L P entity
10% owner
—
$901.92K (1)
−$901.92K
0
0.0000%
$0.00
−100.0%
Lizzul Paul F.
Chief Medical Officer
—
$895.16K (10)
−$895.16K
42,088
0.1446%
$2.42M
+808.2%
Marquet Magda
Director
—
$530.53K (2) scheduled
−$530.53K
9,930
0.0341%
$569.97K
—
Ware J. Anthony
Director
$50.58K (1)
$193.34K (1)
−$142.76K
9,630
0.0331%
$552.75K
—
FENTON DENNIS M
Director
—
$117.45K (2) scheduled
−$117.45K
4,965
0.0171%
$284.99K
—
Gallagher Carol Giltner
Director
—
—
—
64,296
0.2209%
$3.69M
—
Orwin John A
Director
—
—
—
17,995
0.0618%
$1.03M
—
Jain Rita
Director
—
—
—
11,864
0.0408%
$680.98K
—

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
EcoR1 Capital, LLC
2 Jan 2025
Director
Buy indirect
6,646
$12.95
$86.07K
EcoR1 Capital, LLC
31 Dec 2024
Director
Buy indirect
13,268
$12.93
$171.51K
EcoR1 Capital, LLC
30 Dec 2024
Director
Buy indirect
65,184
$12.92
$842.06K
EcoR1 Capital, LLC
14 Aug 2024
10% owner
Buy indirect
273,972
$36.50
$10.00M
EcoR1 Capital, LLC
5 May 2022
10% owner
Buy indirect
668,237
$21.63
$14.45M
EcoR1 Capital, LLC
4 May 2021
Director
Buy indirect
165,000
$23.25
$3.84M
EcoR1 Capital, LLC
3 May 2021
Director
Buy indirect
20,800
$23.31
$484.87K
EcoR1 Capital, LLC
30 Apr 2021
Director
Buy indirect
35,700
$23.16
$826.82K
EcoR1 Capital, LLC
27 Apr 2021
Director
Buy indirect
33,800
$23.82
$805.09K
EcoR1 Capital, LLC
26 Apr 2021
Director
Buy indirect
13,900
$23.80
$330.86K
EcoR1 Capital, LLC
23 Apr 2021
Director
Buy indirect
99,600
$23.54
$2.34M
EcoR1 Capital, LLC
9 Mar 2021
10% owner
Buy indirect
531,000
$18.70
$9.93M
EcoR1 Capital, LLC
8 Mar 2021
10% owner
Buy indirect
2,777,800
$18.97
$52.69M
EcoR1 Capital, LLC
23 Feb 2021
10% owner
Buy indirect
29,500
$25.48
$751.66K
Ware J. Anthony
10 Dec 2019
Director
Buy
3,600
$14.05
$50.58K
Frazier Healthcare V, LP
31 Jan 2017
10% owner
Buy indirect
88,709
$15.00
$1.33M
Frazier Healthcare V, LP
31 Jan 2017
10% owner
Buy indirect
311,291
$15.00
$4.67M
Frazier Healthcare VII, L.P.
31 Jan 2017
10% owner
Buy indirect
88,709
$15.00
$1.33M
Frazier Healthcare VII, L.P.
31 Jan 2017
10% owner
Buy
311,291
$15.00
$4.67M
Lydon Nicholas
31 Jan 2017
Director
Buy
16,666
$15.00
$249.99K
Topper James N
31 Jan 2017
Director
Buy indirect
88,709
$15.00
$1.33M
Topper James N
31 Jan 2017
Director
Buy indirect
311,291
$15.00
$4.67M
Novo Holdings A/S
31 Jan 2017
10% owner
Buy
50,000
$15.00
$750.00K
Show all 179 transactions →

What was left out

Form 4 filings counted 264
Amendments (4/A) skipped 1
Filings about a different issuer 1
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 67
Sales at will 66
Transactions with no price 0
Shares from compensation/vesting 22,373,949
Sales filed before the plan box existed 26
History held since 31 Jan 2017